SA

Sweva Alam Khan

Active Director Director DIN 10695587
DIN 10695587 First appointment Jul 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sweva Alam Khan

Data last updated:

Sweva Alam Khan is a Director at Valansa Lifescience Private Limited (since 2024).

DIN 10695587
Primary Designation Director
First Appointment 04 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Valansa Lifescience Private Limited U86900DL2024PTC433789
Director04 Jul 20242024Active

Board colleagues of Sweva Alam Khan

NameDINCompanyDesignation
Fatima Khatoon10695586Valansa Lifescience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Valansa Lifescience Private Limited
Premium access

Shareholding and investment profile for Sweva Alam Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sweva Alam Khan

Sweva Alam Khan currently holds 1 directorship: Valansa Lifescience Private Limited (Director, since 04 Jul 2024).

Sweva Alam Khan was first appointed on 04 Jul 2024 as Director at Valansa Lifescience Private Limited.

The current boards of Sweva Alam Khan's companies include Fatima Khatoon (Valansa Lifescience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available